Last reviewed: May 19, 2026 Last updated: May 19, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Studies have proposed that modified amino acid substitutions in CJC-1295 could enhance its resistance to enzymatic breakdown, allowing it to maintain activity over longer periods
Minarini A, Ferrari S, Galletti M, Giambalvo N, Perrone D, Rioli G, et al
Severe gastroparesis cases requiring feeding tubes or permanent dietary restrictions may settle in the $400,000 to $700,000 range, while NAION vision loss claims involving permanent blindness could exceed $1 million due to lifetime disability